Dehydrated Human Umbilical Cord Particulate (dHUCP) Device

The FIRST FDA Cleared Human Umbilical Cord-Derived Medical Device Designed to Manage Chronic & Acute Wounds

StimLabs is the first and only company to receive 510(k) FDA clearance for a medical device derived from human birth tissue and intended for wound management. Clearance was achieved by demonstrating the safety and effectiveness of this unique technology through the highest quality standards and rigorous testing.

Advantages of Corplex P¹

Formatted as a particulate for the management of damaged or deficient tissue

Provides a porous scaffold comprised of human extracellular matrix components

Facilitates a moist wound environment through the regulation of moisture exchange

Common Clinical Applications

Corplex P is indicated for use in the management of the following wounds:

Partial & Full-thickness Wounds

Pressure Ulcers

Venous Ulcers

Diabetic Ulcers

Chronic Vascular Ulcers

Tunneled Wounds

Undermined Wounds

Surgical Wounds

Trauma Wounds

Draining Wounds

A Closer Look at the Complex Scaffold¹

Sizes and SKUs

Vial	SKU	Product Volume
	CP-0010	1 cc
	CP-0020	2 cc
	CP-0040	4 cc

For a pourable consistency, introduce the recommended volume of sterile 0.9% saline into the open vial. For a paste consistency, slowly add sterile saline to the particles until the desired consistency is obtained.

Corplex P is for adult use and is not indicated for injection. For detailed product safety and device application information, refer to the Instructions For Use.

Scanning Electron Microscope (SEM), Hyaluronic Acid (HA), Immunohistochemical (IHC)
1. Data on file.
Patents: www.stimlabs.com/patents. US Pub. No. 2024/0024536 A1 (pending US Appl. No. 18/220,928)